Clinical Trial Update: Anti-Cytokine Therapy for Vasculitis [Phase 2]

View source ↗

Summary

Phase 2 trial update of an anti-cytokine therapy for granulomatosis with polyangiitis and related vasculitides; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Renal-limited Vasculitis

Snippet

Sponsor: University Hospital Birmingham NHS Foundation Trust | Conditions: Wegener's Granulomatosis, Renal Limited Vasculitis | Phase 2 | Status: COMPLETED